| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.HYP.29.3.736 |
| P698 | PubMed publication ID | 9052889 |
| P2093 | author name string | A Salvetti | |
| S Taddei | |||
| I Sudano | |||
| A Virdis | |||
| L Ghiadoni | |||
| P Mattei | |||
| C B Fasolo | |||
| P433 | issue | 3 | |
| P921 | main subject | hypertension | Q95566669 |
| P304 | page(s) | 736-743 | |
| P577 | publication date | 1997-03-01 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Hypertension causes premature aging of endothelial function in humans | |
| P478 | volume | 29 |
| Q36208762 | A sympathetic view of the sympathetic nervous system and human blood pressure regulation |
| Q48335448 | Activation of α1A -adrenoceptors desensitizes the rat aorta response to phenylephrine through a neuronal NOS pathway, a mechanism lost with ageing. |
| Q44403122 | Age-related changes in the protective effect of chronic administration of l-arginine on post-ischemic recovery of endothelial function |
| Q35128658 | Age-related endothelial dysfunction : potential implications for pharmacotherapy |
| Q28390251 | Aging and vascular endothelial function in humans |
| Q36528268 | Aging enhances contraction to thromboxane A2 in aorta from female senescence-accelerated mice |
| Q35829890 | Aging-shifted prostaglandin profile in endothelium as a factor in cardiovascular disorders |
| Q35907558 | Are cardiovascular disease and osteoporosis directly linked? |
| Q40218042 | Arginine and antioxidant supplement on performance in elderly male cyclists: a randomized controlled trial |
| Q34144489 | Arterial aging and subclinical arterial disease are fundamentally intertwined at macroscopic and molecular levels |
| Q34144269 | Arterial aging: a journey into subclinical arterial disease |
| Q38542436 | Arterial structure and function in vascular ageing: are you as old as your arteries? |
| Q37326035 | Association of inflammatory gene polymorphisms and conventional risk factors with arterial stiffness by age. |
| Q74183715 | Body fat distribution and flow-mediated endothelium-dependent vasodilation in older men |
| Q37530433 | COX-1 and vascular disease |
| Q38693262 | Cardiovascular Adaptations to Exercise Training |
| Q37000075 | Cardiovascular risk in the metabolic syndrome: fact or fiction? |
| Q42510887 | Comparison of 12-lipoxygenase expression in vascular smooth muscle cells from old normotensive Wistar-Kyoto rats with spontaneously hypertensive rats |
| Q35042816 | Cyclo-oxygenase-1 and -2 contribution to endothelial dysfunction in ageing |
| Q37154250 | Cyclooxygenase inhibition improves endothelial vasomotor dysfunction of visceral adipose arterioles in human obesity. |
| Q44780611 | Different vasodilator responses of human arms and legs |
| Q38964342 | Drug Treatment of Hypertension: Focus on Vascular Health. |
| Q33847029 | Early and late response-to-injury in patients undergoing transradial coronary angiography: arterial remodeling in smokers |
| Q36835831 | Early vascular aging (EVA): consequences and prevention |
| Q46942123 | Effect of age and exercise training on protein:protein interactions among eNOS and its regulatory proteins in rat aortas |
| Q21245073 | Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine |
| Q78738838 | Effects of ageing and regular aerobic exercise on endothelial fibrinolytic capacity in humans |
| Q34510978 | Effects of antihypertensive drugs on endothelial dysfunction: clinical implications |
| Q31935168 | Effects of blood pressure and glucose on endothelial function |
| Q37921394 | Endothelial dysfunction associated with obesity and the effect of weight loss interventions |
| Q36726832 | Endothelin-1, aging and hypertension. |
| Q36442609 | Endothelium, aging, and hypertension |
| Q24650963 | Endothelium-dependent contractions and endothelial dysfunction in human hypertension |
| Q35048636 | Endothelium-dependent contractions in hypertension |
| Q37279644 | Endothelium-dependent contractions: when a good guy turns bad! |
| Q28510643 | Endothelium-dependent relaxations in the aorta from K(2p)6.1 knockout mice |
| Q54069074 | Endothelium-dependent vasodilatation in treated and untreated hypertensive subjects. |
| Q35376020 | Endothelium-mediated control of vascular tone: COX-1 and COX-2 products |
| Q50127484 | Essential Hypertension and Functional Microvascular Ageing. |
| Q44049319 | Evidence for agonist-specific endothelial vasodilator dysfunction with ageing in healthy humans |
| Q90675988 | Exercise Pressor Reflex Contributes to the Cardiovascular Abnormalities Characterizing: Hypertensive Humans During Exercise |
| Q44416309 | Exercise training improves ageing‐induced decrease in eNOS expression of the aorta |
| Q35590906 | Fetal origin of vascular aging |
| Q34905471 | Genetic polymorphism of NOS3 with susceptibility to deep vein thrombosis after orthopedic surgery: a case-control study in Chinese Han population |
| Q36956391 | Habitual exercise and arterial aging |
| Q43543177 | Haemoconcentration, shear-stress increase and carotid artery diameter regulation after furosemide administration in older hypertensives. |
| Q37682645 | Human endothelial dysfunction: EDCFs. |
| Q37728966 | Human endothelial dysfunction: EDRFs |
| Q42550193 | Hypertension and the absence of EDHF-mediated responses favour endothelium-dependent contractions in renal arteries of the rat. |
| Q84006059 | Hypoxia: just say NO? |
| Q35210513 | Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes |
| Q36628959 | Impact of uncontrolled hypertension on 12-month clinical outcomes following below-the-knee arteries (BTK) interventions in patients with critical limb ischemia |
| Q92825269 | Impaired Glymphatic Transport in Spontaneously Hypertensive Rats |
| Q35106116 | Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence |
| Q37391962 | Ketorolac alters blood flow during normothermia but not during hyperthermia in middle-aged human skin |
| Q53382148 | L-Arginine supplementation does not enhance blood flow and muscle performance in healthy and physically active older women. |
| Q44816935 | Local inhibition of nitric oxide and prostaglandins independently reduces forearm exercise hyperaemia in humans |
| Q35990597 | Mechanisms involved in the aging-induced vascular dysfunction |
| Q43754699 | Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocystinemia in normotensive subjects and patients with essential hypertension |
| Q56601690 | Multiple evidence for an early age pro-oxidant state in Down Syndrome patients |
| Q34578133 | Nitrate ingestion: a review of the health and physical performance effects |
| Q34357850 | Nitric oxide, but not vasodilating prostaglandins, contributes to the improvement of exercise hyperemia via ascorbic acid in healthy older adults |
| Q36198670 | Nucleotide excision DNA repair is associated with age-related vascular dysfunction |
| Q41052616 | Potentiation of cGMP signaling increases oxygen delivery and oxidative metabolism in contracting skeletal muscle of older but not young humans. |
| Q84246909 | Prehypertension is associated with impaired nitric oxide-mediated endothelium-dependent vasodilation in sedentary adults |
| Q37410493 | Reactive hyperemia occurs via activation of inwardly rectifying potassium channels and Na+/K+-ATPase in humans |
| Q38533603 | Reduced blood flow to contracting skeletal muscle in ageing humans: is it all an effect of sand through the hourglass? |
| Q28192230 | Role of cyclooxygenase products in the regulation of vascular tone and in the endothelial vasodilator function of normal, hypertensive, and hypercholesterolemic humans |
| Q60637755 | Role of nitric oxide and prostanoids in the regulation of leg blood flow and blood pressure in humans with essential hypertension: effect of high-intensity aerobic training |
| Q85167996 | Role of the nitric oxide metabolic pathway and prostanoids in the pathogenesis of endothelial dysfunction and essential hypertension in young men |
| Q46425807 | SIRT1, heme oxygenase-1 and NO-mediated vasodilation in a human model of endogenous angiotensin II type 1 receptor antagonism: implications for hypertension |
| Q46242575 | Sexual dimorphism and in the aging heart: role of estrogen, nitric oxide and beyond |
| Q38599190 | Single passive leg movement assessment of vascular function: The contribution of nitric oxide |
| Q33710484 | Special considerations in the therapy of diabetic hypertension |
| Q33936152 | Sympathetic nervous system and blood pressure in humans: individualized patterns of regulation and their implications |
| Q36227457 | The antihypertensive effect of ethyl acetate extract of radish leaves in spontaneously hypertensive rats |
| Q73740933 | The detection of endothelial dysfunction in patients with essential hypertension |
| Q60637759 | The hyperaemic response to passive leg movement is dependent on nitric oxide: a new tool to evaluate endothelial nitric oxide function |
| Q40800081 | The role of nitric oxide in passive leg movement-induced vasodilatation with age: insight from alterations in femoral perfusion pressure |
| Q36053698 | The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension |
| Q35158491 | Ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery in clinical research. |
| Q37545073 | Vascular endothelial ageing, heartbeat after heartbeat |
| Q37718071 | Vasoconstrictor prostanoids |
Search more.